Hsieh CY - Search Results

1

Stephania tetrandra and Its Active Compound Coclaurine Sensitize NSCLC Cells to Cisplatin through EFHD2 Inhibition.

Hu SY, Lin TH, Chen CY, He YH, Huang WC, Hsieh CY, Chen YH, Chang WC. Hu SY, et al. Among authors: hsieh cy. Pharmaceuticals (Basel). 2024 Oct 11;17(10):1356. doi: 10.3390/ph17101356. Pharmaceuticals (Basel). 2024. PMID: 39458997 Free PMC article.

2

Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma.

Hsieh CY, Lin CC, Chang WC. Hsieh CY, et al. Biomedicines. 2023 Oct 25;11(11):2887. doi: 10.3390/biomedicines11112887. Biomedicines. 2023. PMID: 38001888 Free PMC article. Review.

3

Glutathione S-transferase omega class 1 (GSTO1)-associated large extracellular vesicles are involved in tumor-associated macrophage-mediated cisplatin resistance in bladder cancer.

Pan YC, Chu PY, Lin CC, Hsieh CY, Hsu WY, Shyur LF, Yang JC, Chang WC, Wu YC. Pan YC, et al. Among authors: hsieh cy. Mol Oncol. 2024 Aug;18(8):1866-1884. doi: 10.1002/1878-0261.13659. Epub 2024 May 15. Mol Oncol. 2024. PMID: 38750006 Free PMC article.

4

Macrophage secretory IL-1β promotes docetaxel resistance in head and neck squamous carcinoma via SOD2/CAT-ICAM1 signaling.

Hsieh CY, Lin CC, Huang YW, Chen JH, Tsou YA, Chang LC, Fan CC, Lin CY, Chang WC. Hsieh CY, et al. JCI Insight. 2022 Dec 8;7(23):e157285. doi: 10.1172/jci.insight.157285. JCI Insight. 2022. PMID: 36264639 Free PMC article.

5

Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase I trial.

Hsieh CY, Lien MY, Lin CY, Lo WJ, Hua CH, Chang WC, Chiu CF, Lin CC. Hsieh CY, et al. BMC Cancer. 2022 Feb 15;22(1):169. doi: 10.1186/s12885-022-09258-0. BMC Cancer. 2022. PMID: 35168547 Free PMC article. Clinical Trial.

6

Combination treatment of arsenic trioxide and osimertinib in recurrent and metastatic head and neck squamous cell carcinoma.

Hsieh CY, Chang WC, Lin CC, Chen JH, Lin CY, Liu CH, Lin C, Hung MC. Hsieh CY, et al. Am J Cancer Res. 2022 Nov 15;12(11):5049-5061. eCollection 2022. Am J Cancer Res. 2022. PMID: 36504903 Free PMC article.

7

Programmed Death Ligand-1 and Tumor Burden Score Dictate Treatment Responses in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

Lien MY, Wang CC, Hwang TZ, Hsieh CY, Yang CC, Wang CC, Lien CF, Shih YC, Yeh SA, Hsieh MC. Lien MY, et al. Among authors: hsieh cy, hsieh mc. Cancers (Basel). 2024 Apr 30;16(9):1748. doi: 10.3390/cancers16091748. Cancers (Basel). 2024. PMID: 38730699 Free PMC article.

8

Prognostic analysis of adjuvant chemotherapy in patients with nasopharyngeal carcinoma.

Lin CC, Chen TT, Lin CY, Hsieh CY, Lin PH, Chien CR, Chiu CF, Yeh SP. Lin CC, et al. Among authors: hsieh cy. Future Oncol. 2013 Oct;9(10):1469-76. doi: 10.2217/fon.13.100. Future Oncol. 2013. PMID: 24106898

9

Safety and efficacy of pegylated liposomal doxorubicin-based adjuvant chemotherapy in patients with stage I-III triple-negative breast cancer.

Lien MY, Liu LC, Wang HC, Yeh MH, Chen CJ, Yeh SP, Bai LY, Liao YM, Lin CY, Hsieh CY, Lin CC, Li LY, Lin PH, Chiu CF. Lien MY, et al. Among authors: hsieh cy. Anticancer Res. 2014 Dec;34(12):7319-26. Anticancer Res. 2014. PMID: 25503167 Clinical Trial.

10

Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study.

Hsieh CY, Lein MY, Yang SN, Wang YC, Lin YJ, Lin CY, Hua CH, Tsai MH, Lin CC. Hsieh CY, et al. BMC Cancer. 2020 Sep 1;20(1):832. doi: 10.1186/s12885-020-07347-6. BMC Cancer. 2020. PMID: 32873270 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

922 results

Search Page

Filters